Asset profile
Rituximab
Monoclonal antibody
Approvedregulatory verdict
Evidence outlook
Approved: Rheumatoid Arthritis
Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.
track record: Reliable signal
Featured evidence outside covered markets:MAINRITSEG (NCT03164473) · Eosinophilic Granulomatosis With Polyangiitis · Phase 3 · missed primary endpoint · Partial signal
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
70 competitors in this universe: 5 direct rivals (same mechanism and indication), 10 same-class, 55 same-indication.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| Rituximab: this drug | Approved | Monoclonal antibody | CD20, CD20-directed Cytolytic Antibody | ||
| PF-05280586 | Approved | Biologic (subtype unspecified) | CD20 | ||
| Acellbia | Phase 3 | Monoclonal antibody | CD20 | ||
| CT-P10 | Phase 3 | Monoclonal antibody | CD20 | ||
| HLX01 | Phase 3 | Monoclonal antibody | CD20 | ||
| SAR448501 | Phase 1 | Multispecific antibody | CD20 | ||
| Ocrelizumab | Approved | Monoclonal antibody | CD20 | ||
| Ocrevus Zunovo | Approved | Monoclonal antibody | CD20 | ||
| Ofatumumab | Approved | Monoclonal antibody | CD20 | ||
| Ublituximab | Approved | Monoclonal antibody | CD20 | ||
| ABP 692 | Phase 3 | Monoclonal antibody | CD20 | ||
| BCD-132 | Phase 3 | Monoclonal antibody | CD20 | ||
| BCD-281 | Phase 3 | Monoclonal antibody | CD20 | ||
| CT-P53 | Phase 3 | Monoclonal antibody | CD20 | ||
| Divozilimab | Phase 3 | Monoclonal antibody | CD20 | ||
| MIL62 | Phase 3 | Monoclonal antibody | CD20 |
…and 55 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(327 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (31)
October 2026 (2)
Phase 1Diffuse Large B-cell LymphomaRecruiting
Est. primary completion 2026-10-15 · NCT06977711 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell LymphomaActive not recruiting
Est. primary completion 2026-10-15 · NCT05455697 · CT.gov ↗
What to watch
November 2026 (4)
Phase 1LymphomaActive not recruiting
Est. primary completion 2026-11 · NCT03352765 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaRecruiting
Est. primary completion 2026-11-01 · NCT06263491 · CT.gov ↗
What to watch
Phase 2B Acute Lymphoblastic Leukemia, B Lymphoblastic LymphomaRecruiting
Est. primary completion 2026-11-01 · NCT02877303 · CT.gov ↗
What to watch
Phase 3Primary Immune Thrombocytopenia (ITP)Recruiting
Est. primary completion 2026-11-14 · NCT05338190 · CT.gov ↗
What to watch
December 2026 (25)
Phase 1/2Crohn's DiseaseRecruiting
Est. primary completion 2026-12 · NCT00692939 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2026-12 · NCT03467867 · CT.gov ↗
What to watch
Phase 2/3Relapsed/Refractory Diffuse Large B-cell LymphomaActive not recruiting
Est. primary completion 2026-12 · NCT04442022 · CT.gov ↗
What to watch
Phase 1Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma …Active not recruiting
Est. primary completion 2026-12-01 · NCT01479842 · CT.gov ↗
What to watch
Phase 2IgM MGUS, Waldenstrom Macroglobulinemia, Neuropathy;PeripheralActive not recruiting
Est. primary completion 2026-12-01 · NCT05065554 · CT.gov ↗
What to watch
Phase 2Waldenstrom MacroglobulinemiaRecruiting
Est. primary completion 2026-12-01 · NCT06561347 · CT.gov ↗
What to watch
Phase 1/2Primary Central Nervous System Lymphoma, Recurrent Cancer, Refractory Cancer, Relapsed CancerRecruiting
Est. primary completion 2026-12-05 · NCT04421560 · CT.gov ↗
What to watch
Phase 1Lymphoma, Primary Central Nervous System LymphomaRecruiting
Est. primary completion 2026-12-30 · NCT06475235 · CT.gov ↗
What to watch
Phase 2Immune Thrombocytopenia (ITP)Not yet recruiting
Est. primary completion 2026-12-30 · NCT07057778 · CT.gov ↗
What to watch
Phase 2Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated VasculitisActive not recruiting
Est. primary completion 2026-12-30 · NCT06388941 · CT.gov ↗
What to watch
Phase 2Severe Aplastic Anemia, Platelet Transfusion RefractorinessRecruiting
Est. primary completion 2026-12-30 · NCT06254560 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage II Follicular Lymphoma, Grade 1 Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma …Recruiting
Est. primary completion 2026-12-30 · NCT06471738 · CT.gov ↗
What to watch
Phase 1Refractory Systemic Lupus Erythematosus, Refractory Lupus NephritisRecruiting
Est. primary completion 2026-12-31 · NCT06676631 · CT.gov ↗
What to watch
Phase 1Lymphoma, B-CellActive not recruiting
Est. primary completion 2026-12-31 · NCT04161248 · CT.gov ↗
What to watch
Phase 1Follicular LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT03361852 · CT.gov ↗
What to watch
Phase 1B-Cell Non-Hodgkin Lymphoma-Recurrent, Diffuse Large B-Cell Lymphoma-Recurrent, Follicular Lymphoma-Recurrent …Recruiting
Est. primary completion 2026-12-31 · NCT06209619 · CT.gov ↗
What to watch
Phase 2Chronic Graft Versus Host DiseaseRecruiting
Est. primary completion 2026-12-31 · NCT06046248 · CT.gov ↗
What to watch
Phase 2Relapsed/Refractory Large B-Cell LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT06489808 · CT.gov ↗
What to watch
Phase 2High Titers of Anti-HLA Antibody (MFI ≥5000)Recruiting
Est. primary completion 2026-12-31 · NCT06362967 · CT.gov ↗
What to watch
Phase 2Blastic Plasmacytoid Dendritic Cell NeoplasmRecruiting
Est. primary completion 2026-12-31 · NCT04216524 · CT.gov ↗
What to watch
Phase 2Liver Lymphoma, Mantle Cell LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04115631 · CT.gov ↗
What to watch
Phase 2Mucosa-associated Lymphoid Tissue Lymphoma (MALT)Active not recruiting
Est. primary completion 2026-12-31 · NCT06647732 · CT.gov ↗
What to watch
Phase 2LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT02436707 · CT.gov ↗
What to watch
Phase 3Primary Mediastinal Large B-Cell LymphomaActive not recruiting
Est. primary completion 2026-12-31 · NCT04759586 · CT.gov ↗
What to watch
Phase 4OR Regimen for Relapsed/Refractory Marginal Zone LymphomaRecruiting
Est. primary completion 2026-12-31 · NCT06134284 · CT.gov ↗
What to watch
2027 (133)
January 2027 (10)
Phase 2MCL, Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-01 · NCT05214183 · CT.gov ↗
What to watch
Phase 2Richter Syndrome, Chronic Lymphocytic LeukemiaActive not recruiting
Est. primary completion 2027-01 · NCT04679012 · CT.gov ↗
What to watch
Phase 3Polymyalgia RheumaticaActive not recruiting
Est. primary completion 2027-01 · NCT05533164 · CT.gov ↗
What to watch
Phase 2Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IVActive not recruiting
Est. primary completion 2027-01-01 · NCT05788081 · CT.gov ↗
What to watch
Phase 2Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes, T Cell Receptor Alpha/Beta Depletion, Telomere Biology Disorder …Recruiting
Est. primary completion 2027-01-01 · NCT03579875 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaRecruiting
Est. primary completion 2027-01-08 · NCT06572618 · CT.gov ↗
What to watch
Phase 1/2Malignant TumorsRecruiting
Est. primary completion 2027-01-11 · NCT05615974 · CT.gov ↗
What to watch
Phase 3Lymphoma, Large B-Cell, DiffuseNot yet recruiting
Est. primary completion 2027-01-12 · NCT06573645 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaActive not recruiting
Est. primary completion 2027-01-16 · NCT04978584 · CT.gov ↗
What to watch
Phase 3Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-01-31 · NCT03267433 · CT.gov ↗
What to watch
February 2027 (9)
Phase 2Non-Hodgkin LymphomaRecruiting
Est. primary completion 2027-02 · NCT05583071 · CT.gov ↗
What to watch
Phase 2Sickle Cell Disease, Thalassemia, Beta, ThalassemiaRecruiting
Est. primary completion 2027-02-09 · NCT05736419 · CT.gov ↗
What to watch
Phase 3Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular LymphomaActive not recruiting
Est. primary completion 2027-02-13 · NCT04224493 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Central Nervous System LymphomaRecruiting
Est. primary completion 2027-02-13 · NCT06832267 · CT.gov ↗
What to watch
Phase 3Lymphoma, Mantle CellActive not recruiting
Est. primary completion 2027-02-15 · NCT02972840 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaActive not recruiting
Est. primary completion 2027-02-22 · NCT04529772 · CT.gov ↗
What to watch
Phase 2Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With BCR-ABL1 …Active not recruiting
Est. primary completion 2027-02-28 · NCT03147612 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-02-28 · NCT06522386 · CT.gov ↗
What to watch
Early phase / not applicablePrimacy Immune ThrombocytopeniaRecruiting
Est. primary completion 2027-02-28 · NCT07206823 · CT.gov ↗
What to watch
March 2027 (13)
Phase 2Immune Thrombocytopenia, TreatmentRecruiting
Est. primary completion 2027-03 · NCT07362199 · CT.gov ↗
What to watch
Phase 2Relapsed Mantle Cell Lymphoma, Refractory Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-03 · NCT05249959 · CT.gov ↗
What to watch
Phase 2Relapsed or Refractory Large B-cell LymphomaRecruiting
Est. primary completion 2027-03 · NCT06788964 · CT.gov ↗
What to watch
Phase 3Severe Forms of Mucous Membrane PemphigoidActive not recruiting
Est. primary completion 2027-03 · NCT03295383 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-cell LymphomaActive not recruiting
Est. primary completion 2027-03 · NCT06929624 · CT.gov ↗
What to watch
Phase 2/3Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma …Active not recruiting
Est. primary completion 2027-03-01 · NCT04799275 · CT.gov ↗
What to watch
Phase 3B Acute Lymphoblastic LeukemiaRecruiting
Est. primary completion 2027-03-01 · NCT03150693 · CT.gov ↗
What to watch
Phase 2Large B-Cell Lymphoma With IRF4 Rearrangement, Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma …Recruiting
Est. primary completion 2027-03-03 · NCT06834373 · CT.gov ↗
What to watch
Phase 3Marginal Zone LymphomaActive not recruiting
Est. primary completion 2027-03-18 · NCT04212013 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-03-22 · NCT03710772 · CT.gov ↗
What to watch
Phase 1Lymphoma, Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-03-31 · NCT05495464 · CT.gov ↗
What to watch
Phase 2Type 1 Diabetes MellitusActive not recruiting
Est. primary completion 2027-03-31 · NCT03929601 · CT.gov ↗
What to watch
Phase 4ANCA Associated Vasculitis (AAV)Recruiting
Est. primary completion 2027-03-31 · NCT06611696 · CT.gov ↗
What to watch
April 2027 (13)
Phase 1Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular LymphomaRecruiting
Est. primary completion 2027-04 · NCT07226843 · CT.gov ↗
What to watch
Phase 3Acute Demyelinating Syndrome, Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseRecruiting
Est. primary completion 2027-04 · NCT05545384 · CT.gov ↗
What to watch
Phase 4Hemophagocytic Lymphohistiocytosis, B Cell LymphomaRecruiting
Est. primary completion 2027-04 · NCT07270835 · CT.gov ↗
What to watch
Early phase / not applicableNon Hodgkin Lymphoma (NHL), Diffuse Large B-cell Lymphoma (DLBCL)Active not recruiting
Est. primary completion 2027-04 · NCT01829958 · CT.gov ↗
What to watch
Phase 1Primary Diffuse Large B-Cell Lymphoma of the Central Nervous SystemActive not recruiting
Est. primary completion 2027-04-01 · NCT04609046 · CT.gov ↗
What to watch
Phase 2Primary Membranous NephropathyNot yet recruiting
Est. primary completion 2027-04-01 · NCT07029139 · CT.gov ↗
What to watch
Phase 2B Acute Lymphoblastic Leukemia, B Lymphoblastic LymphomaActive not recruiting
Est. primary completion 2027-04-01 · NCT05303792 · CT.gov ↗
What to watch
Phase 2B-cell Non-Hodgkin's LymphomaActive not recruiting
Est. primary completion 2027-04-06 · NCT07081022 · CT.gov ↗
What to watch
Phase 1/2Lymphoma, Non-HodgkinActive not recruiting
Est. primary completion 2027-04-07 · NCT03930953 · CT.gov ↗
What to watch
Phase 2Lymphoma, Lymphoma, B-CellRecruiting
Est. primary completion 2027-04-14 · NCT06954805 · CT.gov ↗
What to watch
Phase 3ANCA Associated Vasculitis (AAV)Recruiting
Est. primary completion 2027-04-16 · NCT07168161 · CT.gov ↗
What to watch
Phase 2Psychosis, Autoimmune EncephalitisActive not recruiting
Est. primary completion 2027-04-30 · NCT03194815 · CT.gov ↗
What to watch
Early phase / not applicableWaldenström's Macroglobulinemia (WM)Not yet recruiting
Est. primary completion 2027-04-30 · NCT06942507 · CT.gov ↗
What to watch
May 2027 (11)
Phase 1Myeloid DiseasesActive not recruiting
Est. primary completion 2027-05 · NCT03531736 · CT.gov ↗
What to watch
Phase 3Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS …Recruiting
Est. primary completion 2027-05 · NCT05834855 · CT.gov ↗
What to watch
Early phase / not applicableDiffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-05-01 · NCT07072208 · CT.gov ↗
What to watch
Phase 1Pemphigus Vulgaris, Rituximab (RTx)Not yet recruiting
Est. primary completion 2027-05-05 · NCT07769333 · CT.gov ↗
What to watch
Phase 1Recurrent Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-05-15 · NCT05052528 · CT.gov ↗
What to watch
Phase 1/2Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma …Active not recruiting
Est. primary completion 2027-05-20 · NCT01473628 · CT.gov ↗
What to watch
Phase 2Mantle-cell LymphomaRecruiting
Est. primary completion 2027-05-24 · NCT05868395 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2027-05-26 · NCT04458610 · CT.gov ↗
What to watch
Phase 1/2Post-transplant Lymphoproliferative DisorderActive not recruiting
Est. primary completion 2027-05-31 · NCT06040320 · CT.gov ↗
What to watch
Phase 2Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia …Recruiting
Est. primary completion 2027-05-31 · NCT02727803 · CT.gov ↗
What to watch
Phase 2Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL, NHLRecruiting
Est. primary completion 2027-05-31 · NCT04002947 · CT.gov ↗
What to watch
June 2027 (13)
Phase 2Marginal Zone LymphomaActive not recruiting
Est. primary completion 2027-06 · NCT04416451 · CT.gov ↗
What to watch
Phase 3Mature B-cell Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-06 · NCT03206671 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaActive not recruiting
Est. primary completion 2027-06 · NCT05578976 · CT.gov ↗
What to watch
Phase 2Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone LymphomaActive not recruiting
Est. primary completion 2027-06-15 · NCT03697512 · CT.gov ↗
What to watch
Early phase / not applicableMarginal Zone LymphomaRecruiting
Est. primary completion 2027-06-23 · NCT06478472 · CT.gov ↗
What to watch
Phase 1/2Mantle Cell LymphomaRecruiting
Est. primary completion 2027-06-24 · NCT03523975 · CT.gov ↗
What to watch
Phase 1Mature B-cell MalignanciesRecruiting
Est. primary completion 2027-06-25 · NCT06351527 · CT.gov ↗
What to watch
Phase 1Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma …Active not recruiting
Est. primary completion 2027-06-30 · NCT03321643 · CT.gov ↗
What to watch
Phase 1B-cell Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2027-06-30 · NCT06251180 · CT.gov ↗
What to watch
Phase 2Hairy Cell Leukemia, Recurrent Hairy Cell LeukemiaRecruiting
Est. primary completion 2027-06-30 · NCT00412594 · CT.gov ↗
What to watch
Phase 2Glomerulonephritis Rapidly ProgressiveRecruiting
Est. primary completion 2027-06-30 · NCT06047171 · CT.gov ↗
What to watch
Phase 2Blastoid Variant Mantle Cell Lymphoma, Mantle Cell Lymphoma, Pleomorphic Variant Mantle Cell LymphomaActive not recruiting
Est. primary completion 2027-06-30 · NCT02427620 · CT.gov ↗
What to watch
Early phase / not applicableTreatmentActive not recruiting
Est. primary completion 2027-06-30 · NCT07071246 · CT.gov ↗
What to watch
July 2027 (8)
Phase 1Rheumatoid ArthritisRecruiting
Est. primary completion 2027-07 · NCT06581562 · CT.gov ↗
What to watch
Phase 1PTLD, Epstein Barr Virus (EBV) Infection, Solid Organ TransplantNot yet recruiting
Est. primary completion 2027-07 · NCT07614282 · CT.gov ↗
What to watch
Phase 2Marginal Zone LymphomaRecruiting
Est. primary completion 2027-07-08 · NCT06504940 · CT.gov ↗
What to watch
Early phase / not applicableAllogeneic Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Reactivation, Clinically Significant EBV DNAemiaNot yet recruiting
Est. primary completion 2027-07-09 · NCT07703657 · CT.gov ↗
What to watch
Phase 3Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2027-07-10 · NCT06496308 · CT.gov ↗
What to watch
Phase 1Relapsed/Refractory B-cell Non-Hodgkin LymphomaRecruiting
Est. primary completion 2027-07-30 · NCT07073833 · CT.gov ↗
What to watch
Phase 1/2Hematopoietic and Lymphoid System NeoplasmRecruiting
Est. primary completion 2027-07-31 · NCT04022239 · CT.gov ↗
What to watch
Phase 2DLBCL, Lymphoma, B-CellActive not recruiting
Est. primary completion 2027-07-31 · NCT04594798 · CT.gov ↗
What to watch
August 2027 (7)
Phase 1Lupus Nephritis - WHO Class III, Lupus Nephritis - WHO Class IV, Refractory Systemic Lupus Erythematosus, SLEActive not recruiting
Est. primary completion 2027-08 · NCT06265220 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin LymphomaNot yet recruiting
Est. primary completion 2027-08-01 · NCT07159906 · CT.gov ↗
What to watch
Phase 2Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia, Recurrent Burkitt Lymphoma …Recruiting
Est. primary completion 2027-08-01 · NCT03136146 · CT.gov ↗
What to watch
Phase 2Follicular LymphomaRecruiting
Est. primary completion 2027-08-01 · NCT04998669 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma …Recruiting
Est. primary completion 2027-08-03 · NCT04745949 · CT.gov ↗
What to watch
Phase 3Large B-cell LymphomaActive not recruiting
Est. primary completion 2027-08-09 · NCT06356129 · CT.gov ↗
What to watch
Phase 1Mantle Cell LymphomaNot yet recruiting
Est. primary completion 2027-08-10 · NCT07697339 · CT.gov ↗
What to watch
September 2027 (8)
Phase 1/2Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Follicular Lymphoma …Active not recruiting
Est. primary completion 2027-09 · NCT04542824 · CT.gov ↗
What to watch
Phase 1Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma, Ann Arbor Stage IV Mantle Cell LymphomaNot yet recruiting
Est. primary completion 2027-09-01 · NCT07444710 · CT.gov ↗
What to watch
Phase 2Marginal Zone Lymphoma(MZL)Recruiting
Est. primary completion 2027-09-11 · NCT07022223 · CT.gov ↗
What to watch
Phase 2/3DLBCL, Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-09-24 · NCT05139017 · CT.gov ↗
What to watch
Phase 2Lymphoma, Indolent Non-hodgkin LymphomaNot yet recruiting
Est. primary completion 2027-09-29 · NCT06557330 · CT.gov ↗
What to watch
Phase 1/2LymphomaActive not recruiting
Est. primary completion 2027-09-30 · NCT05683171 · CT.gov ↗
What to watch
Phase 1/2Large B-cell LymphomaNot yet recruiting
Est. primary completion 2027-09-30 · NCT07638787 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B-Cell Lymphoma, Follicular LymphomaActive not recruiting
Est. primary completion 2027-09-30 · NCT04663347 · CT.gov ↗
What to watch
October 2027 (9)
Phase 3Large B-Cell LymphomaActive not recruiting
Est. primary completion 2027-10-01 · NCT06047080 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Ocular Adnexal MALT LymphomaNot yet recruiting
Est. primary completion 2027-10-06 · NCT06064344 · CT.gov ↗
What to watch
Phase 1/2Diffuse Large B Cell Lymphoma (DLBCL)Recruiting
Est. primary completion 2027-10-26 · NCT07124936 · CT.gov ↗
What to watch
Phase 1/2Relapsed/Refractory Non-Hodgkin LymphomaRecruiting
Est. primary completion 2027-10-28 · NCT06090539 · CT.gov ↗
What to watch
Phase 2Primary Intraocular LymphomaRecruiting
Est. primary completion 2027-10-30 · NCT06973811 · CT.gov ↗
What to watch
Early phase / not applicableDLBCL - Diffuse Large B Cell LymphomaNot yet recruiting
Est. primary completion 2027-10-30 · NCT07389356 · CT.gov ↗
What to watch
Phase 2Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia …Active not recruiting
Est. primary completion 2027-10-31 · NCT01424982 · CT.gov ↗
What to watch
Early phase / not applicableFibrosing Mediastinitis, Pulmonary HypertensionRecruiting
Est. primary completion 2027-10-31 · NCT06980584 · CT.gov ↗
What to watch
November 2027 (5)
Phase 1Central Nervous System LymphomaActive not recruiting
Est. primary completion 2027-11 · NCT03684980 · CT.gov ↗
What to watch
Phase 2ST Elevated Myocardial InfarctionRecruiting
Est. primary completion 2027-11 · NCT05211401 · CT.gov ↗
What to watch
Phase 2Lymphoma, Mantle-CellRecruiting
Est. primary completion 2027-11-01 · NCT06136351 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2027-11-15 · NCT07001540 · CT.gov ↗
What to watch
Phase 2Hematologic Malignancy, Acute Leukemia, Remission, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, AML, TP53 …Recruiting
Est. primary completion 2027-11-30 · NCT05735717 · CT.gov ↗
What to watch
December 2027 (27)
Phase 1Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma …Recruiting
Est. primary completion 2027-12 · NCT07225439 · CT.gov ↗
What to watch
Phase 1/2Fanconi AnemiaRecruiting
Est. primary completion 2027-12 · NCT04784052 · CT.gov ↗
What to watch
Phase 1/2Idiopathic Pulmonary Fibrosis, Emphysema or COPDRecruiting
Est. primary completion 2027-12 · NCT03500731 · CT.gov ↗
What to watch
Phase 1/2Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome …Active not recruiting
Est. primary completion 2027-12 · NCT04623541 · CT.gov ↗
What to watch
Phase 2T-cell LymphomaActive not recruiting
Est. primary completion 2027-12 · NCT06756308 · CT.gov ↗
What to watch
Phase 2Relapsed B-Cell Non-Hodgkin LymphomaNot yet recruiting
Est. primary completion 2027-12 · NCT07477366 · CT.gov ↗
What to watch
Phase 3Anti-MAG NeuropathyRecruiting
Est. primary completion 2027-12 · NCT05136976 · CT.gov ↗
What to watch
Phase 3Idiopathic Membranous NephropathyRecruiting
Est. primary completion 2027-12 · NCT04745728 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisRecruiting
Est. primary completion 2027-12 · NCT06003283 · CT.gov ↗
What to watch
Phase 1/2Large B-Cell Lymphoma (LBCL)Not yet recruiting
Est. primary completion 2027-12-01 · NCT07269639 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma TreatmentRecruiting
Est. primary completion 2027-12-01 · NCT06946407 · CT.gov ↗
What to watch
Phase 1B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Mixed Phenotype Acute Leukemia …Active not recruiting
Est. primary completion 2027-12-02 · NCT04872790 · CT.gov ↗
What to watch
Phase 2Lymphoma, Large B-Cell, DiffuseRecruiting
Est. primary completion 2027-12-13 · NCT06890884 · CT.gov ↗
What to watch
Phase 2DLBCL - Diffuse Large B Cell LymphomaNot yet recruiting
Est. primary completion 2027-12-20 · NCT07034508 · CT.gov ↗
What to watch
Phase 1/2B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative …Recruiting
Est. primary completion 2027-12-25 · NCT01371630 · CT.gov ↗
What to watch
Phase 2Central Nervous System LymphomaNot yet recruiting
Est. primary completion 2027-12-30 · NCT07405255 · CT.gov ↗
What to watch
Phase 2Primary Mediastinal Diffuse Large B-cell LymphomaRecruiting
Est. primary completion 2027-12-30 · NCT06742502 · CT.gov ↗
What to watch
Phase 2Marginal Zone LymphomaActive not recruiting
Est. primary completion 2027-12-30 · NCT03474744 · CT.gov ↗
What to watch
Phase 2Newly Diagnosed MYC/BCL2 Double-expressor DLBCLActive not recruiting
Est. primary completion 2027-12-31 · NCT07538180 · CT.gov ↗
What to watch
Phase 2Diabetes Mellitus, Type 1Recruiting
Est. primary completion 2027-12-31 · NCT07041268 · CT.gov ↗
What to watch
Phase 2Marginal Zone Lymphoma of Ocular Adnexal, Marginal Zone Lymphoma(MZL)Active not recruiting
Est. primary completion 2027-12-31 · NCT07247383 · CT.gov ↗
What to watch
Phase 2Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative DisorderRecruiting
Est. primary completion 2027-12-31 · NCT05786040 · CT.gov ↗
What to watch
Phase 2Relapsed/Refractory Follicular LymphomaRecruiting
Est. primary completion 2027-12-31 · NCT07418190 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT06441097 · CT.gov ↗
What to watch
Phase 2Mantle-cell LymphomaRecruiting
Est. primary completion 2027-12-31 · NCT07029737 · CT.gov ↗
What to watch
Phase 2Nephrotic Syndrome, Proteinuria, Autoimmune Disease, Glomerular Disease, Membranous GlomerulonephritisRecruiting
Est. primary completion 2027-12-31 · NCT00977977 · CT.gov ↗
What to watch
2028 (79)
January 2028 (5)
Phase 2Rheumatic DiseaseRecruiting
Est. primary completion 2028-01 · NCT07138898 · CT.gov ↗
What to watch
Phase 2Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell LymphomaRecruiting
Est. primary completion 2028-01 · NCT06765317 · CT.gov ↗
What to watch
Phase 2Marginal Zone Lymphoma(MZL)Recruiting
Est. primary completion 2028-01-01 · NCT07448324 · CT.gov ↗
What to watch
Phase 3Thrombocytopenia PurpuraNot yet recruiting
Est. primary completion 2028-01-31 · NCT07051915 · CT.gov ↗
What to watch
February 2028 (2)
March 2028 (7)
Phase 2Waldenstrom Macroglobulinemia, Treatment NaiveRecruiting
Est. primary completion 2028-03 · NCT05099471 · CT.gov ↗
What to watch
Phase 3Rheumatoid ArthritisRecruiting
Est. primary completion 2028-03 · NCT03414502 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaActive not recruiting
Est. primary completion 2028-03 · NCT06508658 · CT.gov ↗
What to watch
Phase 2Ann Arbor Stage III Grade 1 Follicular Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma …Active not recruiting
Est. primary completion 2028-03-01 · NCT04404088 · CT.gov ↗
What to watch
Phase 1/2Aggressive B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage III Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 3 Follicular Lymphoma …Active not recruiting
Est. primary completion 2028-03-21 · NCT05025800 · CT.gov ↗
What to watch
Phase 2Follicular Lymphoma (FL)Not yet recruiting
Est. primary completion 2028-03-30 · NCT07550855 · CT.gov ↗
What to watch
Phase 2Lymphoplasmacytic Lymphoma, Waldenstrom MacroglobulinemiaRecruiting
Est. primary completion 2028-03-31 · NCT04840602 · CT.gov ↗
What to watch
April 2028 (8)
Phase 1/2Double Expressor DLBCLNot yet recruiting
Est. primary completion 2028-04-01 · NCT07415980 · CT.gov ↗
What to watch
Phase 2Obsessive-Compulsive Disorder, Obsessive-Compulsive Behavior, Schizophrenia, Delusional Disorder, Brief Psychotic Disorder …Enrolling by invitation
Est. primary completion 2028-04-01 · NCT04323566 · CT.gov ↗
What to watch
Phase 2/3Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Double-Expressor Lymphoma …Active not recruiting
Est. primary completion 2028-04-01 · NCT03984448 · CT.gov ↗
What to watch
Phase 2Waldenstrom Macroglobulinemia, Lymphoplasmacytic LymphomaRecruiting
Est. primary completion 2028-04-11 · NCT07231952 · CT.gov ↗
What to watch
Phase 3Follicular LymphomaRecruiting
Est. primary completion 2028-04-24 · NCT06911502 · CT.gov ↗
What to watch
Phase 1Primary Central Nervous System LymphomaActive not recruiting
Est. primary completion 2028-04-28 · NCT06541665 · CT.gov ↗
What to watch
Phase 1AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified …Not yet recruiting
Est. primary completion 2028-04-30 · NCT07649304 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2028-04-30 · NCT06803693 · CT.gov ↗
What to watch
May 2028 (3)
Phase 2Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Gastric Mucosa-Associated Lymphoid Tissue Lymphoma, Marginal Zone Lymphoma …Recruiting
Est. primary completion 2028-05-02 · NCT07583810 · CT.gov ↗
What to watch
Phase 1/2Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)Not yet recruiting
Est. primary completion 2028-05-30 · NCT07601607 · CT.gov ↗
What to watch
Phase 2Non-hodgkin LymphomaRecruiting
Est. primary completion 2028-05-31 · NCT05998642 · CT.gov ↗
What to watch
June 2028 (10)
Phase 3Ocular Myasthenia GravisRecruiting
Est. primary completion 2028-06 · NCT06342544 · CT.gov ↗
What to watch
Phase 3Primary Central Nervous System LymphomaActive not recruiting
Est. primary completion 2028-06 · NCT04931368 · CT.gov ↗
What to watch
Phase 1Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma, Plasmablastic Lymphoma, B-Cell NeoplasmRecruiting
Est. primary completion 2028-06-01 · NCT05389423 · CT.gov ↗
What to watch
Phase 1/2Combination Therapy, Aggressive B-Cell Non-Hodgkin Lymphoma, EMB07, phaseI/IIRecruiting
Est. primary completion 2028-06-30 · NCT07432022 · CT.gov ↗
What to watch
Phase 2Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic LymphomaActive not recruiting
Est. primary completion 2028-06-30 · NCT02007044 · CT.gov ↗
What to watch
Phase 2Richter SyndromeActive not recruiting
Est. primary completion 2028-06-30 · NCT03899337 · CT.gov ↗
What to watch
Phase 2Waldenström Macroglobulinemia (WM)Not yet recruiting
Est. primary completion 2028-06-30 · NCT07259122 · CT.gov ↗
What to watch
Phase 2Leukemia, LymphomaActive not recruiting
Est. primary completion 2028-06-30 · NCT01446133 · CT.gov ↗
What to watch
Phase 3Glomerulonephritis, Membranous, Nephrotic Syndrome，IdiopathicActive not recruiting
Est. primary completion 2028-06-30 · NCT05914155 · CT.gov ↗
What to watch
Phase 3Diffuse Large B Cell LymphomaRecruiting
Est. primary completion 2028-06-30 · NCT05018520 · CT.gov ↗
What to watch
July 2028 (12)
Phase 3Follicular LymphomaActive not recruiting
Est. primary completion 2028-07 · NCT05058404 · CT.gov ↗
What to watch
Phase 3Relapsed/Refractory Follicular Lymphoma, Marginal Zone LymphomaActive not recruiting
Est. primary completion 2028-07 · NCT05100862 · CT.gov ↗
What to watch
Phase 4Diffuse Large B-Cell Lymphoma (DLBCL)Not yet recruiting
Est. primary completion 2028-07 · NCT07760610 · CT.gov ↗
What to watch
Phase 4Oncology, Infusion ReactionRecruiting
Est. primary completion 2028-07 · NCT06031233 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2028-07-01 · NCT07199296 · CT.gov ↗
What to watch
Phase 2Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified …Recruiting
Est. primary completion 2028-07-01 · NCT06905509 · CT.gov ↗
What to watch
Phase 3Interstitial Lung Disease With Systemic SclerosisRecruiting
Est. primary completion 2028-07-08 · NCT06549231 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell Lymphoma (DLBCL)Recruiting
Est. primary completion 2028-07-30 · NCT07397832 · CT.gov ↗
What to watch
Phase 1Glioma of Spinal Cord, Glioma of BrainstemRecruiting
Est. primary completion 2028-07-31 · NCT04196413 · CT.gov ↗
What to watch
Phase 2B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1 …Recruiting
Est. primary completion 2028-07-31 · NCT07224100 · CT.gov ↗
What to watch
Phase 2CCND1 Positive, CCND2 Positive, CCND3 Positive, CD20 Positive, Mantle Cell Lymphoma, Recurrent Mantle Cell Lymphoma …Active not recruiting
Est. primary completion 2028-07-31 · NCT01880567 · CT.gov ↗
What to watch
Phase 2Large B-cell LymphomaRecruiting
Est. primary completion 2028-07-31 · NCT06045247 · CT.gov ↗
What to watch
August 2028 (9)
Early phase / not applicablePrimary Central Nervous System Lymphoma, Diffuse Large B-Cell LymphomaNot yet recruiting
Est. primary completion 2028-08 · NCT07764601 · CT.gov ↗
What to watch
Phase 1Immune-Related Adverse EventsNot yet recruiting
Est. primary completion 2028-08-01 · NCT07694414 · CT.gov ↗
What to watch
Phase 1/2Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan AnemiaRecruiting
Est. primary completion 2028-08-01 · NCT03653338 · CT.gov ↗
What to watch
Phase 2Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease, Pulmonary HypertensionRecruiting
Est. primary completion 2028-08-01 · NCT03630211 · CT.gov ↗
What to watch
Phase 2Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Mantle Cell Lymphoma …Recruiting
Est. primary completion 2028-08-01 · NCT06839053 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2028-08-10 · NCT06522555 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaActive not recruiting
Est. primary completion 2028-08-30 · NCT04765111 · CT.gov ↗
What to watch
Phase 2Non-Hodgkin's B-cell Lymphoma, Lymphoma Non-Hodgkin, Diffuse Large B-Cell Lymphoma (DLBCL)Not yet recruiting
Est. primary completion 2028-08-31 · NCT07588698 · CT.gov ↗
What to watch
Phase 3Relapsed/Refractory Marginal Zone LymphomaRecruiting
Est. primary completion 2028-08-31 · NCT06082102 · CT.gov ↗
What to watch
September 2028 (4)
Phase 1Waldenström Macroglobulinemia (WM)Not yet recruiting
Est. primary completion 2028-09-01 · NCT07169565 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2028-09-10 · NCT07272499 · CT.gov ↗
What to watch
Phase 2DLBCL - Diffuse Large B Cell LymphomaRecruiting
Est. primary completion 2028-09-30 · NCT07255963 · CT.gov ↗
What to watch
Phase 2/3Primary Central Nervous System LymphomaRecruiting
Est. primary completion 2028-09-30 · NCT07185373 · CT.gov ↗
What to watch
October 2028 (5)
Phase 2Lymphoma, Marginal Zone Lymphoma, MZLRecruiting
Est. primary completion 2028-10 · NCT06510309 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaRecruiting
Est. primary completion 2028-10 · NCT05635162 · CT.gov ↗
What to watch
Phase 1/2Leukemia, Relapsed Leukemia, Chronic Lymphocytic Leukemia, Relapsed Cancer, Refractory LeukemiaRecruiting
Est. primary completion 2028-10-01 · NCT06644183 · CT.gov ↗
What to watch
Phase 2Diffuse Large B Cell LymphomaNot yet recruiting
Est. primary completion 2028-10-01 · NCT06516978 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma (MCL)Active not recruiting
Est. primary completion 2028-10-31 · NCT05951959 · CT.gov ↗
What to watch
November 2028 (4)
Phase 2Immune Thrombocytopenia, TreatmentRecruiting
Est. primary completion 2028-11 · NCT07234019 · CT.gov ↗
What to watch
Phase 2Primary CNS LymphomaRecruiting
Est. primary completion 2028-11-02 · NCT04627753 · CT.gov ↗
What to watch
Phase 3Systemic SclerosisNot yet recruiting
Est. primary completion 2028-11-14 · NCT07335562 · CT.gov ↗
What to watch
Phase 2Phase 2 Study, MCL, BTKi, Rituximab, GlofitamabRecruiting
Est. primary completion 2028-11-24 · NCT07257055 · CT.gov ↗
What to watch
December 2028 (10)
Phase 1Lymphoma, B-CellActive not recruiting
Est. primary completion 2028-12-01 · NCT04884035 · CT.gov ↗
What to watch
Phase 3DLBCL - Diffuse Large B Cell LymphomaRecruiting
Est. primary completion 2028-12-15 · NCT06220032 · CT.gov ↗
What to watch
Phase 2KSHV Inflammatory Cytokine Syndrome (KICS), KSHV, HHV-8Recruiting
Est. primary completion 2028-12-31 · NCT01419561 · CT.gov ↗
What to watch
Phase 2PCNSL, Primary Central Nervous System LymphomaRecruiting
Est. primary completion 2028-12-31 · NCT07350850 · CT.gov ↗
What to watch
Phase 2Primary Central Nervous System Lymphoma (PCNSL), Secondary Central Nervous System Lymphoma (SCNSL)Recruiting
Est. primary completion 2028-12-31 · NCT07410520 · CT.gov ↗
What to watch
Phase 3Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2028-12-31 · NCT06792253 · CT.gov ↗
What to watch
Phase 4Lupus NephritisRecruiting
Est. primary completion 2028-12-31 · NCT05207358 · CT.gov ↗
What to watch
Early phase / not applicableLupus NephritisNot yet recruiting
Est. primary completion 2028-12-31 · NCT07675291 · CT.gov ↗
What to watch
Early phase / not applicableEBV Infection After Allogenic HSCTRecruiting
Est. primary completion 2028-12-31 · NCT07693881 · CT.gov ↗
What to watch
2029 (33)
January 2029 (2)
February 2029 (1)
Phase 4Primary Immune Thrombocytopenia (ITP)Recruiting
Est. primary completion 2029-02-10 · NCT04518475 · CT.gov ↗
What to watch
March 2029 (3)
Phase 2Follicular Lymphoma, Marginal Zone Lymphoma, B-Cell LymphomaRecruiting
Est. primary completion 2029-03 · NCT06350318 · CT.gov ↗
What to watch
Phase 2Membranous Nephropathy, Nephrotic SyndromeRecruiting
Est. primary completion 2029-03-01 · NCT03949855 · CT.gov ↗
What to watch
Phase 2B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic LymphomaRecruiting
Est. primary completion 2029-03-30 · NCT06918431 · CT.gov ↗
What to watch
April 2029 (4)
Phase 1Large B-cell Lymphoma, Central Nervous System LymphomaNot yet recruiting
Est. primary completion 2029-04 · NCT07608731 · CT.gov ↗
What to watch
Phase 3Primary Mediastinal LymphomaRecruiting
Est. primary completion 2029-04-01 · NCT06188676 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2029-04-22 · NCT05952024 · CT.gov ↗
What to watch
Phase 2Lymphoma, Large B-Cell, Diffuse (DLBCL)Active not recruiting
Est. primary completion 2029-04-26 · NCT05406401 · CT.gov ↗
What to watch
May 2029 (3)
Phase 3Splenic Marginal Zone LymphomaActive not recruiting
Est. primary completion 2029-05 · NCT05735834 · CT.gov ↗
What to watch
Phase 1/2Follicular Lymphoma, Marginal Zone LymphomaRecruiting
Est. primary completion 2029-05-30 · NCT04669171 · CT.gov ↗
What to watch
Phase 2Large B-Cell Lymphoma (LBCL)Not yet recruiting
Est. primary completion 2029-05-31 · NCT07594899 · CT.gov ↗
What to watch
June 2029 (2)
Phase 1/2Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma, B-cell Non-Hodgkin LymphomaRecruiting
Est. primary completion 2029-06-11 · NCT06564038 · CT.gov ↗
What to watch
Phase 2Large B-Cell Lymphoma (LBCL)Not yet recruiting
Est. primary completion 2029-06-30 · NCT07717177 · CT.gov ↗
What to watch
July 2029 (5)
Phase 1/2Leukemia, Lymphocytic, Chronic, B-Cell, B-Lymphocytic Leukemia, Chronic, B-Cell Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia …Recruiting
Est. primary completion 2029-07-01 · NCT06364423 · CT.gov ↗
What to watch
Phase 3Diffuse Large B-Cell LymphomaRecruiting
Est. primary completion 2029-07-02 · NCT06717347 · CT.gov ↗
What to watch
Phase 2Follicular Lymphoma, Marginal Zone LymphomaRecruiting
Est. primary completion 2029-07-08 · NCT06792825 · CT.gov ↗
What to watch
Phase 1AML/MDS, B-ALL, T-ALL, BPDCNRecruiting
Est. primary completion 2029-07-29 · NCT04318678 · CT.gov ↗
What to watch
Phase 4Rheumatoid ArthritisNot yet recruiting
Est. primary completion 2029-07-31 · NCT07643038 · CT.gov ↗
What to watch
August 2029 (1)
Phase 2Waldenstrom MacroglobulinemiaNot yet recruiting
Est. primary completion 2029-08-01 · NCT07464210 · CT.gov ↗
What to watch
September 2029 (1)
Phase 3Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2029-09-30 · NCT06943872 · CT.gov ↗
What to watch
October 2029 (1)
Phase 2Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified …Recruiting
Est. primary completion 2029-10-15 · NCT07365306 · CT.gov ↗
What to watch
November 2029 (3)
Phase 1Central Nervous System LymphomaRecruiting
Est. primary completion 2029-11 · NCT06607549 · CT.gov ↗
What to watch
Phase 2Mantle Cell Lymphoma, LymphomaRecruiting
Est. primary completion 2029-11-01 · NCT06854003 · CT.gov ↗
What to watch
Phase 1/2Mature B-Cell Non-Hodgkin LymphomaRecruiting
Est. primary completion 2029-11-30 · NCT05533775 · CT.gov ↗
What to watch
December 2029 (7)
Phase 2Diffuse Large B-cell LymphomaRecruiting
Est. primary completion 2029-12 · NCT06664411 · CT.gov ↗
What to watch
Phase 3Follicular Lymphoma (FL)Active not recruiting
Est. primary completion 2029-12 · NCT05409066 · CT.gov ↗
What to watch
Phase 4Epstein-Barr Virus InfectionsRecruiting
Est. primary completion 2029-12-01 · NCT04989491 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-Cell Lymphoma (DLBCL)Recruiting
Est. primary completion 2029-12-30 · NCT07493148 · CT.gov ↗
What to watch
Phase 2Mantle Cell LymphomaRecruiting
Est. primary completion 2029-12-31 · NCT05245656 · CT.gov ↗
What to watch
Phase 2BTK Inhibitors, Histone Deacetylase Inhibitor, Double Express Diffuse Large B-cell LymphomaNot yet recruiting
Est. primary completion 2029-12-31 · NCT06890585 · CT.gov ↗
What to watch
Early phase / not applicablePrimary Ocular Adnexal MALT LymphomaRecruiting
Est. primary completion 2029-12-31 · NCT06190301 · CT.gov ↗
What to watch
2030 (19)
January 2030 (1)
Phase 1/2Lysosomal Diseases, Gangliosidosis, GM1Recruiting
Est. primary completion 2030-01-01 · NCT03952637 · CT.gov ↗
What to watch
February 2030 (1)
Phase 4ANCA Associated Vasculitis (AAV), Polyangiitis (GPA), Microscopic Polyangiitis (MPA)Not yet recruiting
Est. primary completion 2030-02 · NCT07451847 · CT.gov ↗
What to watch
March 2030 (4)
Phase 2B Lymphoblastic LeukemiaRecruiting
Est. primary completion 2030-03 · NCT06336395 · CT.gov ↗
What to watch
Phase 2/3Waldenstrom MacroglobulinemiaRecruiting
Est. primary completion 2030-03 · NCT04061512 · CT.gov ↗
What to watch
Phase 1/2Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia, Refractory Hairy Cell LeukemiaRecruiting
Est. primary completion 2030-03-01 · NCT06965114 · CT.gov ↗
What to watch
Phase 2Follicular Lymphoma, Lymphoma, Non-Hodgkin Lymphoma, Relapsed Lymphoma, Refractory Lymphoma, Marginal Zone LymphomaRecruiting
Est. primary completion 2030-03-01 · NCT06563596 · CT.gov ↗
What to watch
April 2030 (3)
Phase 2Diffuse Large B Cell Non-Hodgkin LymphomaRecruiting
Est. primary completion 2030-04 · NCT06835530 · CT.gov ↗
What to watch
Phase 1/2Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell LymphomaNot yet recruiting
Est. primary completion 2030-04-21 · NCT07578077 · CT.gov ↗
What to watch
Phase 1CNS LymphomaRecruiting
Est. primary completion 2030-04-30 · NCT06730542 · CT.gov ↗
What to watch
May 2030 (2)
Phase 2B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified …Recruiting
Est. primary completion 2030-05-31 · NCT07097363 · CT.gov ↗
What to watch
Phase 3Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications …Recruiting
Est. primary completion 2030-05-31 · NCT03394365 · CT.gov ↗
What to watch
June 2030 (1)
Phase 1/2Post-transplant Lymphoproliferative DisorderNot yet recruiting
Est. primary completion 2030-06 · NCT07573436 · CT.gov ↗
What to watch
July 2030 (2)
September 2030 (1)
Phase 2Idiopathic Pulmonary FibrosisNot yet recruiting
Est. primary completion 2030-09-30 · NCT07674745 · CT.gov ↗
What to watch
October 2030 (2)
Phase 1Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma …Not yet recruiting
Est. primary completion 2030-10-08 · NCT07714421 · CT.gov ↗
What to watch
Phase 2Classic Follicular Lymphoma, Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular LymphomaNot yet recruiting
Est. primary completion 2030-10-31 · NCT07731789 · CT.gov ↗
What to watch
December 2030 (2)
Phase 1Kidney Failure, Transplant Recipient (Kidney), Transplant Tolerance, Immunosuppresion, Immunosuppression After Kidney TransplantationActive not recruiting
Est. primary completion 2030-12-31 · NCT06972069 · CT.gov ↗
What to watch
Phase 2Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity, LymphomaRecruiting
Est. primary completion 2030-12-31 · NCT07654426 · CT.gov ↗
What to watch
2031 (13)
January 2031 (1)
Phase 2/3Diffuse Large B-Cell Lymphoma (DLBCL)Not yet recruiting
Est. primary completion 2031-01 · NCT07712588 · CT.gov ↗
What to watch
February 2031 (3)
Phase 1/2Non Hodgkin Lymphoma, Solid TumorRecruiting
Est. primary completion 2031-02 · NCT07222631 · CT.gov ↗
What to watch
Phase 1Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaRecruiting
Est. primary completion 2031-02-10 · NCT05091424 · CT.gov ↗
What to watch
Phase 2Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements …Recruiting
Est. primary completion 2031-02-22 · NCT03418038 · CT.gov ↗
What to watch
April 2031 (2)
Phase 3Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)Recruiting
Est. primary completion 2031-04-30 · NCT06149286 · CT.gov ↗
What to watch
Early phase / not applicableMarginal Zone Lymphoma(MZL)Not yet recruiting
Est. primary completion 2031-04-30 · NCT07299331 · CT.gov ↗
What to watch
May 2031 (2)
June 2031 (1)
Phase 3Mantle Cell LymphomaRecruiting
Est. primary completion 2031-06-25 · NCT06363994 · CT.gov ↗
What to watch
August 2031 (1)
Phase 3Membranous NephropathyRecruiting
Est. primary completion 2031-08-31 · NCT06341205 · CT.gov ↗
What to watch
December 2031 (3)
Phase 1/2Kidney Failure, Kidney Transplant; Complications, ChimeraRecruiting
Est. primary completion 2031-12 · NCT05900401 · CT.gov ↗
What to watch
Phase 2Marginal Zone LymphomaRecruiting
Est. primary completion 2031-12 · NCT06390956 · CT.gov ↗
What to watch
Phase 3Autoimmune Prematur Ovarian InsuffienceRecruiting
Est. primary completion 2031-12-31 · NCT07509840 · CT.gov ↗
What to watch
2032 (9)
January 2032 (1)
Phase 1Relapsed or Refractory B-cell Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2032-01 · NCT06824701 · CT.gov ↗
What to watch
March 2032 (2)
May 2032 (1)
Phase 4Pemphigus, Dermatologic DiseaseRecruiting
Est. primary completion 2032-05-01 · NCT05898308 · CT.gov ↗
What to watch
July 2032 (1)
Phase 2/3Follicular LymphomaRecruiting
Est. primary completion 2032-07-23 · NCT07634471 · CT.gov ↗
What to watch
October 2032 (1)
Phase 1/2SIOD, Cystinosis, FSGS, SLE Nephritis, CKD Stage 4Recruiting
Est. primary completion 2032-10 · NCT05508009 · CT.gov ↗
What to watch
November 2032 (1)
Phase 2Non-Hodgkin LymphomaActive not recruiting
Est. primary completion 2032-11 · NCT05283720 · CT.gov ↗
What to watch
December 2032 (2)
2033 (3)
February 2033 (1)
Phase 2Mantle Cell Lymphoma (MCL)Recruiting
Est. primary completion 2033-02-10 · NCT06846489 · CT.gov ↗
What to watch
May 2033 (1)
Phase 1/2B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaRecruiting
Est. primary completion 2033-05 · NCT07520006 · CT.gov ↗
What to watch
November 2033 (1)
Phase 2/3Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements, Refractory Burkitt Lymphoma …Not yet recruiting
Est. primary completion 2033-11-01 · NCT07724457 · CT.gov ↗
What to watch
2035 (3)
January 2035 (1)
Phase 3Follicular LymphomaNot yet recruiting
Est. primary completion 2035-01-13 · NCT07736950 · CT.gov ↗
What to watch
May 2035 (1)
Phase 2Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal HemoglobinuriaRecruiting
Est. primary completion 2035-05-01 · NCT06412497 · CT.gov ↗
What to watch
October 2035 (1)
Phase 3Richter Syndrome, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma …Not yet recruiting
Est. primary completion 2035-10-01 · NCT07220187 · CT.gov ↗
What to watch
2037 (2)
2038 (1)
August 2038 (1)
Phase 3Mantle Cell LymphomaRecruiting
Est. primary completion 2038-08-31 · NCT05976763 · CT.gov ↗
What to watch
2042 (1)
July 2042 (1)
Phase 1GlioblastomaActive not recruiting
Est. primary completion 2042-07 · NCT06973096 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.